4.7 Article

Human mesenchymal stem cells derived from adipose tissue showed a more robust effect than those from the umbilical cord in promoting corneal graft survival by suppressing lymphangiogenesis

Related references

Note: Only part of the references are listed.
Review Engineering, Biomedical

Progress and emerging techniques for biomaterial-based derivation of mesenchymal stem cells (MSCs) from pluripotent stem cells (PSCs)

Nityanand Prakash et al.

Summary: The use of mesenchymal stem cells (MSCs) in clinical applications has significantly increased in the past decade due to their differentiation potential and immunomodulatory properties. However, the heterogeneity among MSC sources, as well as limitations in adult-sourced MSCs, have posed challenges for their effective use. Recent research has focused on generating MSCs from pluripotent stem cells (PSCs), such as induced pluripotent stem cells (iPSCs), to overcome these limitations.

BIOMATERIALS RESEARCH (2023)

Article Engineering, Biomedical

Exosomes-loaded thermosensitive hydrogels for corneal epithelium and stroma regeneration

Qiaomei Tang et al.

Summary: In this study, a novel approach based on exosomes and a thermosensitive hydrogel was developed for the treatment of corneal diseases. This method effectively reduces scar formation and accelerates the healing process by promoting the repair of damaged corneal epithelium and stromal layer.

BIOMATERIALS (2022)

Article Cell Biology

Human mesenchymal stem cells

Xiaoyong Chen et al.

Summary: Mesenchymal stem cells (MSCs) have potential for cell therapy and tissue regeneration due to their properties, but their heterogeneity poses challenges. The "Human Mesenchymal Stem Cells" guidelines provide standards for quality control and technical specifications, aiming to accelerate the international standardization of MSCs for clinical development and therapeutic applications.

CELL PROLIFERATION (2022)

Article Cell Biology

The Death Receptor Pathway of Apoptosis

Douglas R. Green

Cold Spring Harbor Perspectives in Biology (2022)

Article Ophthalmology

Risk factors of rejection after penetrating keratoplasty: a retrospective monocentric study

Eloi Debourdeau et al.

Summary: This study aimed to assess the risk factors for rejection after penetrating keratoplasty (PKP). The study found that prior indication for graft rejection, history of corneal neovascularization, and high intraocular pressure were significant risk factors for graft rejection after PKP.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2022)

Review Cell & Tissue Engineering

Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review

Ria Margiana et al.

Summary: MSCs have great potential for immunomodulation and tissue regeneration, and can be used for the treatment of various diseases. Recent advances in MSCs biology have facilitated their clinical application.

STEM CELL RESEARCH & THERAPY (2022)

Article Endocrinology & Metabolism

Stem Cell Therapy Improves Human Islet Graft Survival in Mice via Regulation of Macrophages

Wenyu Gou et al.

Summary: Transplantation of human alpha-1 antitrypsin-engineered mesenchymal stromal cells improves survival of human islet grafts posttransplantation by inhibiting macrophage migration and shifting macrophages to a protective state that favors islet survival.

DIABETES (2022)

Review Immunology

Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells

Madina Sarsenova et al.

Summary: The review summarizes various approaches to enhance the clinical outcomes of mesenchymal stem cell (MSC) therapy and revises current and future perspectives for the creation of improved cellular products with potential for diverse clinical applications.

FRONTIERS IN IMMUNOLOGY (2022)

Review Ophthalmology

Corneal graft failure: an update

Jorge L. Alio et al.

Summary: Corneal graft surgery is a successful form of tissue transplantation, but still faces relevant risk of failure due to factors like immunological rejection, late endothelial failure, and ocular surface disorders. Different surgical techniques have varying rates of failure, with penetrating keratoplasty having higher failure rates than lamellar keratoplasty.

BRITISH JOURNAL OF OPHTHALMOLOGY (2021)

Article Surgery

Myeloid-derived suppressor cells improve corneal graft survival through suppressing angiogenesis and lymphangiogenesis

Yuerong Ren et al.

Summary: Myeloid-derived suppressor cells (MDSC) play a negative role in immune responses and tumor progression through pro-angiogenic activity and immunosuppressive functions. However, they have been shown to regulate neovascularization post-transplantation. Ex vivo generated MDSC may potentially serve as a valuable agent for inducing anti-angiogenic regulation.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Article Biochemistry & Molecular Biology

Comparative Proteomic Analysis of the Mesenchymal Stem Cells Secretome from Adipose, Bone Marrow, Placenta and Wharton’s Jelly

Sungho Shin et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Ophthalmology

Efficacy of Immunosuppressants in High Rejection Risk Keratoplasty: A Meta-Analysis of Comparative Studies

Kang Yu et al.

Summary: This study found that FK506 eye drops, MMF, and systemic CsA were considered promising management strategies to prevent rejection in high-risk penetrating keratoplasty.

CORNEA (2021)

Editorial Material Cell Biology

Adipose Tissue-Derived Mesenchymal Stem Cells

Bruce A. Bunnell

Summary: This article discusses the importance and potential clinical applications of stem cells within adipose tissue, which are multipotent and secrete various cytokines.

CELLS (2021)

Review Ophthalmology

Mesenchymal stromal cells for corneal transplantation: Literature review and suggestions for successful clinical trials

Joo Youn Oh et al.

Summary: Despite advancements in surgical techniques and understanding of rejection pathways, corticosteroids remain the main immunosuppressive regimen for corneal transplantation with 15-year survival rates still low. Mesenchymal stromal cells (MSCs) have emerged as a promising cell therapy to promote transplant tolerance and prevent rejection in both corneal and solid organ transplantation.

OCULAR SURFACE (2021)

Article Cell & Tissue Engineering

Subconjunctival administration of low-dose murine allogeneic mesenchymal stromal cells promotes corneal allograft survival in mice

Oliver Treacy et al.

Summary: The study showed that low-dose subconjunctival injection of allogeneic MSCs effectively promoted corneal allograft survival, indicating a potential for improving future MSC immunotherapies for preventing corneal allograft rejection.

STEM CELL RESEARCH & THERAPY (2021)

Review Cell Biology

Lymphatic Trafficking in the Eye: Modulation of Lymphatic Trafficking to Promote Corneal Transplant Survival

Yanhong Hou et al.

Summary: Lymphangiogenesis in the cornea is a critical risk factor for allograft rejection, and modulating lymphatic trafficking may promote corneal graft survival. Inhibition of lymphangiogenesis or regression of existing lymphatic vessels has been shown to improve transplant survival. Blocking antigen presenting cell trafficking to lymph nodes can also enhance allograft survival in high-risk eyes.

CELLS (2021)

Review Cell Biology

New therapeutic approaches of mesenchymal stem cells-derived exosomes

Jana Janockova et al.

Summary: Mesenchymal stem cells (MSCs) are shown to have great potential in treating diseases through the secretion of exosomes, which are believed to be more effective than the cells themselves. Alternative approaches using MSC-derived exosomes offer promise in overcoming limitations in cell-based therapy. MSC-derived exosomes have significant therapeutic potential and are promising in regenerative medicine.

JOURNAL OF BIOMEDICAL SCIENCE (2021)

Article Cell Biology

Adult mesenchymal stem cell ageing interplays with depressed mitochondrial Ndufs6

Yuelin Zhang et al.

CELL DEATH & DISEASE (2020)

Article Cell & Tissue Engineering

Mesenchymal Stromal Cells Modulate Corneal Alloimmunity via Secretion of Hepatocyte Growth Factor

Sharad K. Mittal et al.

STEM CELLS TRANSLATIONAL MEDICINE (2019)

Review Immunology

Mesenchymal Stromal Cells for Transplant Tolerance

Manuel Alfredo Podesta et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Biochemistry & Molecular Biology

Therapeutic approaches for induction of tolerance and immune quiescence in corneal allotransplantation

Maryam Tahvildari et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2018)

Editorial Material Critical Care Medicine

Mesenchymal Stromal Cell Therapy: Does the Source Matter?

Sailaja Ghanta et al.

CRITICAL CARE MEDICINE (2018)

Review Ophthalmology

Angiogenesis and lymphangiogenesis in corneal transplantation-A review

Wei Zhong et al.

SURVEY OF OPHTHALMOLOGY (2018)

Article Cell & Tissue Engineering

A Pilot Study of Mesenchymal Stem Cell Therapy for Acute Liver Allograft Rejection

Ming Shi et al.

STEM CELLS TRANSLATIONAL MEDICINE (2017)

Article Medicine, Research & Experimental

Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue

June Seok Heo et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)

Review Immunology

Alloimmunity and Tolerance in Corneal Transplantation

Afsaneh Amouzegar et al.

JOURNAL OF IMMUNOLOGY (2016)

Article Ophthalmology

Global Survey of Corneal Transplantation and Eye Banking

Philippe Gain et al.

JAMA OPHTHALMOLOGY (2016)

Article Cell & Tissue Engineering

Human Umbilical Cord Mesenchymal Stem Cells: A New Era for Stem Cell Therapy

Dah-Ching Ding et al.

CELL TRANSPLANTATION (2015)

Article Ophthalmology

Mesenchymal stem cells improve healing of the cornea after alkali injury

Diamantis Almaliotis et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2015)

Article Multidisciplinary Sciences

Adipose-Derived Mesenchymal Stem Cell Administration Does Not Improve Corneal Graft Survival Outcome

Sherezade Fuentes-Julian et al.

PLOS ONE (2015)

Article Cell & Tissue Engineering

First-in-Human Case Study: Multipotent Adult Progenitor Cells for Immunomodulation After Liver Transplantation

Yorick Soeder et al.

STEM CELLS TRANSLATIONAL MEDICINE (2015)

Article Dentistry, Oral Surgery & Medicine

Effects of Hypoxia on the Immunomodulatory Properties of Human Gingiva-Derived Mesenchymal Stem Cells

C. M. Jiang et al.

JOURNAL OF DENTAL RESEARCH (2015)

Article Ophthalmology

Application of Adipose-Derived Stem Cells on Scleral Contact Lens Carrier in an Animal Model of Severe Acute Alkaline Burn

Ladan Espandar et al.

EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE (2014)

Article Biochemistry & Molecular Biology

Tissue factor triggers procoagulation in transplanted mesenchymal stem cells leading to thromboembolism

Kohei Tatsumi et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)

Review Biochemistry & Molecular Biology

Adipose tissue-derived stem cells show considerable promise for regenerative medicine applications

Izabela Harasymiak-Krzyzanowska et al.

CELLULAR & MOLECULAR BIOLOGY LETTERS (2013)

Editorial Material Cell & Tissue Engineering

Autoimmune T Cells Lured to a FASL Web of Death by MSCs

William J. Murphy et al.

CELL STEM CELL (2012)

Article Cell & Tissue Engineering

Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell Apoptosis

Kentaro Akiyama et al.

CELL STEM CELL (2012)

Article Cell & Tissue Engineering

Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?

Guido Moll et al.

STEM CELLS (2012)

Article Veterinary Sciences

Retro-orbital injections in mice

Tal Yardeni et al.

LAB ANIMAL (2011)

Article Cell & Tissue Engineering

Immune Properties of Human Umbilical Cord Wharton's Jelly-Derived Cells

Mark L. Weiss et al.

STEM CELLS (2008)

Review Cell Biology

Molecular regulation of angiogenesis and lymphangiogenesis

Ralf H. Adams et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)